Where does Visby Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Visby Medical, Inc. ranks #15,049 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Visby Medical, Inc. hold?

Visby Medical, Inc. holds 20 US utility patents granted between 2020 and 2025, spanning 7 technology areas.

What is Visby Medical, Inc.'s Innovation Score?

Visby Medical, Inc. has an Innovation Score of 36.0 out of 100 (top 47% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Visby Medical, Inc. focus on?

Visby Medical, Inc.'s top technology area is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE) with 15 patents, ranking #124 of 1,325 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Visby Medical, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Visby Medical, Inc..

What does claim depth mean for Visby Medical, Inc.'s patents?

Visby Medical, Inc.'s patents average 17.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Visby Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Visby Medical, Inc.

USPTO PatentsView assignee record - 20 granted patents across 7 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01L (Chemical OR Physical Laboratory Apparatus FOR General USE).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Visby ranks #15,049 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 7 technology areas.

#15,049
of 49,997 US assignees by volume: Top 47%
by Innovation Score (36.0/100): 17.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R15049 · US Corporation #15,049 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-SMALL 20 grants
MID-PACK #15,049/49,997
PHOTO-FINISH Vicarious Surgical
CPC-NARROW B01L · 7 areas
INNOV-THIN 36.0/100
CLAIMS-RICH 17.3 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Vicarious Surgical Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Visby’s 36.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.5 pts (29%) Velocity 5.8 pts (16%) Breadth 9.4 pts (26%) Claim depth 10.4 pts (29%)

Qualcomm Incorporated · highest

85
Visby Medical · this assignee

36
3D Lighting… · lowest

7

What this shows Visby's Innovation Score is 36.0/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Visby?

Each dot is one of Visby’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Visby’s own 17.3 claims/patent is ABOVE the 16.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Visby vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Visby's grants concentrate

Visby Medical, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 75% of grants classified under B01L (Chemical OR Physical Laboratory Apparatus FOR General USE). Peak complete grant year is 2021 (6 grants) versus a trough of 2 in 2020. By volume, Visby sits between Vicarious Surgical Inc. and Winix Inc..

Visby's three-year grant acceleration

Visby Medical, Inc. shows 7 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Vicarious Surgical

20
Videomining

20
Videri

20
Vintech Industries

20
Visuray Intech (B…

20
W O M World OF Me…

20
Wavefront Technol…

20
Winix

20
Visby Medical ◀

20

What this shows Visby holds 20 patents at rank #15,042, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Visby

By rank, the assignees closest to #15,042 in granted patent volume.

Leaders in B01L (Chemical OR Physical Laboratory Apparatus FOR General USE)

Other assignees with the most granted patents in Visby's primary technology class.

Visby's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 47% higher than 53% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Visby Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	2	10.0%
2021	6	30.0%
2022	3	15.0%
2024	4	20.0%
2025partial year	5	25.0%

Which technologies does Visby Medical, Inc. patent most?

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 15

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 13

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

H05B - Electric HEATING; Electric Light Sources NOT Otherwise Provided FOR; Circuit Arrangements FOR Electric Light Sources, IN General 3

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

C12Y - Enzymes 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Visby Medical, Inc.'s patent record in context - here's where to go next.

Visby Medical, Inc.'s lead technology class is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), 75% of its portfolio - see every assignee active in that class. Explore B01L
Ranked #15,049 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Visby Medical, Inc. against Vicarious Surgical Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.